| Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia AO Ahmed, B Kirkpatrick, S Galderisi, A Mucci, A Rossi, A Bertolino, ... Schizophrenia bulletin 45 (2), 305-314, 2019 | 132 | 2019 |
| Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM A Mané, C Falcon, JJ Mateos, E Fernandez-Egea, G Horga, F Lomeña, ... Schizophrenia research 114 (1-3), 136-143, 2009 | 120 | 2009 |
| Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study D Bergé, A Mané, P Salgado, R Cortizo, C Garnier, L Gomez, C Diez-Aja, ... Psychiatric Services 67 (2), 227-233, 2016 | 105 | 2016 |
| Relationship between cannabis and psychosis: Reasons for use and associated clinical variables A Mané, M Fernández-Expósito, D Bergé, L Gómez-Pérez, A Sabaté, ... Psychiatry research 229 (1-2), 70-74, 2015 | 77 | 2015 |
| Spanish adaptation and validation of the Brief Negative Symptoms Scale A Mané, C García-Rizo, MP Garcia-Portilla, D Bergé, G Sugranyes, ... Comprehensive Psychiatry 55 (7), 1726-1729, 2014 | 65 | 2014 |
| The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study G Mezquida, B Cabrera, M Bioque, S Amoretti, A Lobo, A González-Pinto, ... Schizophrenia Research 189, 84-90, 2017 | 63 | 2017 |
| Modelling gene-environment interaction in first episodes of psychosis M Bernardo, M Bioque, B Cabrera, A Lobo, A González-Pinto, L Pina, ... Schizophrenia research 189, 181-189, 2017 | 56 | 2017 |
| Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with … A Lafuente, M Bernardo, S Mas, A Crescenti, M Aparici, P Gasso, ... Psychiatry research 161 (2), 131-141, 2008 | 54 | 2008 |
| Atypical depression is associated with suicide attempt in bipolar disorder V Sánchez‐Gistau, F Colom, A Mane, S Romero, G Sugranyes, E Vieta Acta Psychiatrica Scandinavica 120 (1), 30-36, 2009 | 53 | 2009 |
| Brain-derived neurotrophic factor levels in first episode of psychosis: a systematic review A Toll, A Mané World journal of psychiatry 5 (1), 154, 2015 | 47 | 2015 |
| Examining gene–environment interactions using aggregate scores in a first-episode psychosis cohort S Mas, D Boloc, N Rodríguez, G Mezquida, S Amoretti, MJ Cuesta, ... Schizophrenia Bulletin 46 (4), 1019-1025, 2020 | 46 | 2020 |
| Default mode network aberrant connectivity associated with neurological soft signs in schizophrenia patients and unaffected relatives L Galindo, D Bergé, GK Murray, A Mané, A Bulbena, V Pérez, O Vilarroya Frontiers in psychiatry 8, 298, 2018 | 43 | 2018 |
| 18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia E Fernandez-Egea, E Parellada, F Lomena, C Falcon, J Pavia, A Mane, ... European archives of psychiatry and clinical neuroscience 260, 69-76, 2010 | 43 | 2010 |
| Differential brain glucose metabolic patterns in antipsychotic-naive first-episode schizophrenia with and without auditory verbal hallucinations G Horga, E Parellada, F Lomeña, E Fernández-Egea, A Mané, M Font, ... Journal of Psychiatry and Neuroscience 36 (5), 312-321, 2011 | 40 | 2011 |
| Inverse association between negative symptoms and body mass index in chronic schizophrenia G Mezquida, G Savulich, C Garcia-Rizo, MP Garcia-Portilla, A Toll, ... Schizophrenia research 192, 69-74, 2018 | 39 | 2018 |
| Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique S Amoretti, N Verdolini, G Mezquida, FD Rabelo-da-Ponte, MJ Cuesta, ... European Neuropsychopharmacology 47, 112-129, 2021 | 38 | 2021 |
| Cannabis use, COMT, BDNF and age at first-episode psychosis A Mané, D Bergé, MJ Penzol, M Parellada, M Bioque, A Lobo, ... Psychiatry Research 250, 38-43, 2017 | 38 | 2017 |
| A prospective study contrasting the psychiatric outcome in drug‐resistant epilepsy between patients who underwent surgery and a control group S Ramos‐Perdigués, E Baillés, A Mané, M Carreño, A Donaire, J Rumia, ... Epilepsia 57 (10), 1680-1690, 2016 | 37 | 2016 |
| An observational study of clozapine induced sedation and its pharmacological management SR Perdigués, RS Quecuti, A Mané, L Mann, C Mundell, ... European Neuropsychopharmacology 26 (1), 156-161, 2016 | 37 | 2016 |
| Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia M Bioque, G Mezquida, S Amoretti, C García-Rizo, JM López-Ilundain, ... Schizophrenia Research 243, 32-42, 2022 | 34 | 2022 |
